▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

CDW Corp. Q3 22 Earnings Conference Call At 8:30 AM ET

By RTTNews Staff Writer ✉ | Published: 11/2/2022 7:31 AM ET

CDW Corporation (CDW) will host a conference call at 8:30 AM ET on Nov. 2, 2022, to discuss Q3 22 earnings results.

To access the live webcast, log on to https://investor.cdw.com/events-and-presentations/default.aspx

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2023

Biotech Stocks Facing FDA Decision In June 2023

Biotech Stocks Facing FDA Decision In April 2023

Biotech Stocks Facing FDA Decision In April 2023

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In March 2023

Latest Updates on COVID-19

FDA Approves Pfizer's COVID-19 Pill Paxlovid

US Revokes Covid Vaccination Requirement For International Air Travel

Read More

COVID-19: Drugs in Development

RELATED NEWS

CDW Corp. Q1 23 Earnings Conference Call At 8:30 AM ET

CDW Corporation Q1 Profit Decreases, but beats estimates

CDW Stock Slips 13% On Q1 Preliminary Results

Follow RTT

Editor's Pick
Most Read
Most Emailed

Inditex Stock Up On Q1 Profit Growth; Sees Flat Margin In FY23

CPSC Warns Against Recalled Boppy Newborn Loungers After More Infant Deaths

Apple Unveils Vision Pro Headset, IOS 17, 15-inch MacBook Air And More

Domino's Offers 50% Off Online Deal Through June 11

Frozen RTE Beef Chili Products Supplied Through NSLP Recalled

Boeing, NASA Further Delay Starliner Crew Flight Launch

Chervon Recalls EGO Power+ Cordless Brushless Hedge Trimmers

E.N.A. Meat Packing Recalls Frozen, Raw Lamb Products

Dechra Pharma Agrees To Be Acquired By EQT's Freya Bidco For 3,875p/share In Cash

AstraZeneca Reports Positive Results From Interim Analysis Of DESTINY-PanTumor02 Phase II Trial

Novartis Says Kisqali And Endocrine Therapy Reduces Cancer Recurrence Risk By 25%

Novavax Signs Deal With Bill & Melinda Gates Research Institute To Provide Matrix-M Adjuvant

MorphoSys To Release Myelofibrosis Trial Data This Year

MEI Pharma Promotes COO David Urso To Succeed Daniel Gold As President And CEO

Evotec Gets $1.7 Mln Grant For Discovery Of RNA-targeting Henipavirus Therapeutics

Bellerophon Therapeutics: Phase 3 REBUILD Trial Fails To Meet Primary Endpoint

CIRCOR Int'l To Be Taken Private By KKR In $1.6 Bln All-cash Deal

Barnes Group To Acquire MB Aerospace

Foghorn : FDA Lifts Clinical Hold On Phase 1 Study Of FHD-286 In Relapsed And/or Refractory AML/MDS

Hoth Therapeutics' Alzheimer's Disease Drug Yields Positive Results In Preclinical Study

MEI Pharma Promotes COO David Urso To Succeed Daniel Gold As President And CEO

GSK's Arexvy, RSV Vaccine For Older Adults, Authorized By European Commission

Paragon Banking To Commence Share Buy-back As Part Of Review Of Capital Management

Chemring H1 Profit Declines, Revenue Down 4%; Full Year Expectations Unchanged

CIRCOR Int'l To Be Taken Private By KKR In $1.6 Bln All-cash Deal

PainReform's Phase 3 Trial Of PRF-110 Delayed Due To Supplier Issue

Campbell Soup Co. Bottom Line Retreats In Q3

EV Startup Fisker To Enter Emission Credits Market

J. Jill Group Profit Drops In Q1 - Update

Grubhub, Amazon Renew 1-Year Free Grubhub+ Membership For U.S. Prime Subscribers

Dechra Pharma Agrees To Be Acquired By EQT's Freya Bidco For 3,875p/share In Cash

Vodafone Gains On Upcoming UK Merger With Hutchinson